Amneal Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US03168L1052

SecurityAMRX / Amneal Pharmaceuticals, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership559,432 shares
Latest Disclosed Value $ 7,049,143
Sei Investments Co reports 18.75% increase in ownership of AMRX / Amneal Pharmaceuticals, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 559,432 shares of Amneal Pharmaceuticals, Inc. (US:AMRX) valued at $7,048,843 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 471,107 shares of Amneal Pharmaceuticals, Inc.. This represents a change in shares of 18.75% during the quarter. The current value of the position is $7,202,687 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 559,432 88,325 18.75 7,049 49.50 0.0070
2025-11-13 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 471,107 16,594 3.65 4,715 28.26 0.0051
2025-08-14 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 454,513 96,608 26.99 3,677 22.57 0.0043
2025-05-14 2025-03-31 13F/A-1 AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 357,905 18,444 5.43 2,999 11.57 0.0039
2025-05-13 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 340,816 1,355 2,710 0.0029
2025-02-11 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 339,461 42,743 14.41 2,689 8.91 0.0035
2024-11-12 2024-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 296,718 169,618 133.45 2,469 205.82 0.0032
2024-08-13 2024-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 127,100 91,584 257.87 807 275.35 0.0011
2024-05-07 2024-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 35,516 11,534 48.09 215 48.28 0.0003
2024-02-14 2023-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 23,982 850 3.67 146 49.48 0.0002
2023-11-14 2023-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 23,132 -6,232 -21.22 98 6.59 0.0002
2023-08-11 2023-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 29,364 10,198 53.21 91 250.00 0.0002
2023-05-12 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 19,166 2,572 15.50 27 -21.21 0.0000
2023-02-10 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 16,594 -642 -3.72 33 -5.71 0.0001
2022-11-14 2022-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 17,236 -726 -4.04 35 -2.78 0.0001
2022-08-15 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 17,962 -2,591 -12.61 36 -41.94 0.0001
2022-05-13 2022-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 20,553 3,096 17.74 62 6.90 0.0001
2022-02-14 2021-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 17,457 -94,622 -84.42 58 -90.07 0.0001
2021-11-12 2021-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 112,079 -10,751 -8.75 584 -5.19 0.0012
2021-08-06 2021-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 122,830 93,312 316.12 616 258.14 0.0014
2021-05-12 2021-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 29,518 29,518 172 0.0004
2021-02-08 2020-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 0 -13,866 -100.00 0 -100.00
2020-12-04 2020-09-30 13F/A-1 AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 13,866 -546 -3.79 51 -25.00 0.0001
2020-11-06 2020-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 13,866 -546 51 122.7967
2020-08-17 2020-06-30 13F/A-1 AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 14,412 350 2.49 68 51.11 0.0002
2020-08-11 2020-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 14,412 350 68 184.4536
2020-05-14 2020-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 14,062 2,223 18.78 45 -13.46 0.0002
2020-02-06 2019-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 11,839 -2,401 -16.86 52 40.54 0.0002
2019-11-12 2019-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 14,240 2,007 16.41 37 -56.98 0.0001
2019-08-14 2019-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 12,233 4,710 62.61 86 -25.86 0.0003
2019-05-15 2019-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 7,523 491 6.98 116 14.85 0.0004
2019-02-13 2018-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 7,032 1,028 17.12 101 -24.63 0.0004
2018-11-08 2018-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 6,004 -2,488 -29.30 134 -3.60 0.0005
2018-08-03 2018-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 8,492 8,492 139 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.